|
Abiraterone Acetate
|
Zytiga®
|
250 / 500mg
Tablets
|
Prostate Cancer
|
|
Cabozantinib
|
Cabometyx®
|
20 / 40 / 60 mg
Tablets
|
Renal Cell and Hepatocellular Carcinomas, Differentiated Thyroid Cancer
|
|
Eltrombopag
|
Revolade® / Promacta®
|
12.5 / 25 / 50 / 75 mg
Tablets
|
Thrombocytopenia, Severe Aplastic Anemia
|
|
Enzalutamide
|
Xtandi®
|
40mg, 80mg, 120mg, 160mg
Tablets
|
Prostate Cancer
|
|
Fingolimod
|
Gilenya®
|
0.25 / 0.5 mg
Capsules
|
Multiple Sclerosis
|
|
Ibrutinib
|
Imbruvica®
|
140 / 280 / 420 / 560 mg
Tablets
|
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Waldenström’s Macroglobulinemia, Mantle Cell Lymphoma (1), Chronic Graft-Versus-Host Disease (2)
|
|
Lenvatinib
|
Lenvima® / Kisplyx®
|
4 / 10 mg
Capsules
|
Renal Cell, Hepatocellular and Endometrial Carcinomas, Differentiated Thyroid Cancer
|
|
Nilotinib
|
Tasigna®
|
50 / 150 / 200 mg
Capsules
|
Chronic Myeloid Leukemia
|
|
Olaparib
|
Lynparza ®
|
100 / 150 mg
Tablets
|
Ovarian, Breast, Pancreatic and Prostate Cancer
|
|
Palbociclib
|
Ibrance®
|
75 / 100 / 125 mg
Tablets
|
Breast Cancer
|
|
Palbociclib
|
Ibrance®
|
75 / 100 / 125 mg
Capsules
|
Breast Cancer
|
|
Pazopanib
|
Votrient®
|
200 / 400 mg
Tablets
|
Renal Cell Carcinoma, Soft Tissue Sarcoma
|
|
Pomalidomide
|
Imnovid® / Pomalyst®
|
1 / 2 / 3 / 4 mg
Capsules
|
Multiple Myeloma, Kaposi Sarcoma (2)
|
|
Ruxolitinib
|
Jakavi® / Jakafi®
|
5 / 10 / 15 / 20 / 25 mg
Tablets
|
Myelofibrosis, Polycythemia Vera, Acute and Chronic Graft-Versus-Host Disease
|
|
Sunitinib
|
Sutent®
|
12.5 / 25 / 37.5 / 50 mg
Capsules
|
Gastrointestinal Stromal Tumor, Renal Cell Carcinoma
|
|
Tofacitinib
|
Xeljanz®
|
5 / 10 mg
Tablets
|
Rheumatoid and Psoriatic Arthritis, Ulcerative Colitis, Ankylosing Spondylitis, Polyarticular Course Juvenile Idiopathic Arthritis
|
|
Tofacitinib XR
|
Xeljanz XR®
|
11 / 22 mg
Tablets
|
Rheumatoid and Psoriatic Arthritis, Ulcerative Colitis, Ankylosing Spondylitis
|